40472-97-7Relevant academic research and scientific papers
ANTAGONIST COMPOUNDS
-
Paragraph 00368; 00404, (2022/02/09)
The present invention relates to compounds of formula (I) shown below: wherein R1, R2, R3, R4, R5 and R6 are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a and/or A2b receptor activity is implicated, such as, for example, cancer.
PHARMACEUTICAL COMPOUND FOR TREATMENT OF INFLAMMATORY DISEASES
-
Paragraph 0131-0134, (2016/10/08)
The present invention relates to a pharmaceutical composition for treating inflammatory diseases, and is characterized by being a compound represented by chemical formula I or a pharmaceutically acceptable salt, hydrate, or solvate thereof. The present invention can provide a compound which interacts with or interrupts the 5-LOX-pathway, especially, a compound having an effect of inhibiting arachidonate 5-lipoxygenase.COPYRIGHT KIPO 2015
